Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108182273 | 10818227 | 3 | F | 2013 | 20160718 | 20150218 | 20160721 | EXP | US-PFIZER INC-2015058793 | PFIZER | 65.00 | YR | F | Y | 87.98000 | KG | 20160721 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108182273 | 10818227 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, DAILY | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | |||||||
| 108182273 | 10818227 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG, 1X/DAY | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 108182273 | 10818227 | 3 | C | VALPROIC ACID. | VALPROIC ACID | 1 | 250 MG, AS NEEDED | 0 | 250 | MG | |||||||||
| 108182273 | 10818227 | 4 | C | BACLOFEN. | BACLOFEN | 1 | 20 MG, 3X/DAY | C0801015A | 0 | 20 | MG | TID | |||||||
| 108182273 | 10818227 | 5 | C | BACLOFEN. | BACLOFEN | 1 | 20 MG, 1X/DAY (ONCE AT NIGHT) | 0 | 20 | MG | QD | ||||||||
| 108182273 | 10818227 | 6 | C | DIAZEPAM. | DIAZEPAM | 1 | Oral | 5 MG, 2X/DAY | 106028A | 0 | 5 | MG | TABLET | BID | |||||
| 108182273 | 10818227 | 7 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 800 MG, DAILY | 0 | 800 | MG | TABLET | |||||||
| 108182273 | 10818227 | 8 | C | SUMATRIPTAN SUCCINATE. | SUMATRIPTAN SUCCINATE | 1 | 50 MG, AS NEEDED (1 OR 2 TABLETS AS NEEDED) | 0 | 50 | MG | TABLET | ||||||||
| 108182273 | 10818227 | 9 | C | METHYLPHENIDATE. | METHYLPHENIDATE | 1 | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | |||||||
| 108182273 | 10818227 | 10 | C | METHYLPHENIDATE. | METHYLPHENIDATE | 1 | 0 | TABLET | |||||||||||
| 108182273 | 10818227 | 11 | C | METHYLPHENIDATE. | METHYLPHENIDATE | 1 | 0 | TABLET | |||||||||||
| 108182273 | 10818227 | 12 | C | CLARITIN | LORATADINE | 1 | 10 MG TABLET ONE EVERY TWO WEEKS | 0 | 10 | MG | TABLET | ||||||||
| 108182273 | 10818227 | 13 | C | CLARITIN | LORATADINE | 1 | 0 | TABLET | |||||||||||
| 108182273 | 10818227 | 14 | C | BUPROPION HCL ER | BUPROPION HYDROCHLORIDE | 1 | 100 MG, 1X/DAY, (ONCE A DAY IN MORNING) | 0 | 100 | MG | TABLET | QD | |||||||
| 108182273 | 10818227 | 15 | C | BUPROPION HCL ER | BUPROPION HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
| 108182273 | 10818227 | 16 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 108182273 | 10818227 | 1 | Major depression |
| 108182273 | 10818227 | 2 | Crying |
| 108182273 | 10818227 | 3 | Headache |
| 108182273 | 10818227 | 4 | Muscle spasms |
| 108182273 | 10818227 | 5 | Pain |
| 108182273 | 10818227 | 8 | Migraine |
| 108182273 | 10818227 | 9 | Disturbance in attention |
| 108182273 | 10818227 | 10 | Somnolence |
| 108182273 | 10818227 | 11 | Fatigue |
| 108182273 | 10818227 | 12 | Asthma |
| 108182273 | 10818227 | 13 | Hypersensitivity |
| 108182273 | 10818227 | 14 | Energy increased |
| 108182273 | 10818227 | 15 | Insomnia |
| 108182273 | 10818227 | 16 | Disturbance in attention |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 108182273 | 10818227 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 108182273 | 10818227 | Blood glucose decreased | |
| 108182273 | 10818227 | Brain injury | |
| 108182273 | 10818227 | Concussion | |
| 108182273 | 10818227 | Fall | |
| 108182273 | 10818227 | Hallucination | |
| 108182273 | 10818227 | Loss of consciousness | |
| 108182273 | 10818227 | Optic nerve injury | |
| 108182273 | 10818227 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 108182273 | 10818227 | 2 | 201001 | 0 | ||
| 108182273 | 10818227 | 4 | 201411 | 0 | ||
| 108182273 | 10818227 | 6 | 2011 | 0 | ||
| 108182273 | 10818227 | 8 | 201409 | 0 | ||
| 108182273 | 10818227 | 9 | 201406 | 0 | ||
| 108182273 | 10818227 | 12 | 2008 | 0 | ||
| 108182273 | 10818227 | 14 | 2009 | 0 |